Hepatocellular carcinoma in patients with non-alcoholic steatohepatitis

被引:267
作者
Shimada, M
Hashimoto, E
Taniai, M
Hasegawa, K
Okuda, H
Hayashi, N
Takasaki, K
Ludwig, J
机构
[1] Tokyo Womens Med Univ, Inst Gastroenterol, Shinjuku Ku, Tokyo 1628666, Japan
[2] Mayo Clin, Div Anat Pathol, Rochester, MN USA
关键词
cirrhosis; hepatocellular carcinoma; non-alcoholic steatohepatitis;
D O I
10.1016/S0168-8278(02)00099-5
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
We describe six patients with non-alcoholic steatohepatitis (NASH) and hepatocellular carcinoma (HCC). From 1990 to 2001, we treated 82 patients with NASH and observed six patients (three men and three women, aged 56-72 years) in this group who were referred with HCC or developed the complication during follow-up. In five of these six patients, NASH was associated with obesity (cases 3, 4 and 5), hyperlipidemia (case 5), or diabetes mellitus (cases 1, 3 and 6). We confirmed the presence of HCC by ultrasonography-guided tumor biopsy or surgery except in case 3 where we diagnosed the tumor by ultrasonography, computed tomography and selective hepatic arteriography. The carcinomas measured 1.5-6.0 cm in diameter and three were well differentiated. When HCC was diagnosed, cirrhosis was present in all instances. Four of the six tumor patients also had esophageal varices but only one patient had a history of variceal bleeding and ascites. Treatment of HCC consisted of surgery (cases 1 and 5), transcatheter arterial embolization or infusion and/or percutaneous ethanol injection (cases 2, 3, 4, and 6). In patients with NASH cirrhosis, the development of treatable HCC is sufficiently common to warrant regular screening for this grave complication. (C) 2002 European Association for the Study of the Liver. Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:154 / 160
页数:7
相关论文
共 20 条
[1]   FATTY LIVER HEPATITIS AND CIRRHOSIS IN OBESE PATIENTS [J].
ADLER, M ;
SCHAFFNER, F .
AMERICAN JOURNAL OF MEDICINE, 1979, 67 (05) :811-816
[2]   Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis [J].
Angulo, P ;
Keach, JC ;
Batts, KP ;
Lindor, KD .
HEPATOLOGY, 1999, 30 (06) :1356-1362
[3]   NONALCOHOLIC STEATOHEPATITIS - AN EXPANDED CLINICAL ENTITY [J].
BACON, BR ;
FARAHVASH, MJ ;
JANNEY, CG ;
NEUSCHWANDERTETRI, BA .
GASTROENTEROLOGY, 1994, 107 (04) :1103-1109
[4]   Clinical management of hepatocellular carcinoma.: Conclusions of the Barcelona-2000 EASL Conference [J].
Bruix, J ;
Sherman, M ;
Llovet, JM ;
Beaugrand, M ;
Lencioni, R ;
Burroughs, AK ;
Christensen, E ;
Pagliaro, L ;
Colombo, M ;
Rodés, J .
JOURNAL OF HEPATOLOGY, 2001, 35 (03) :421-430
[5]  
Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x
[6]   Nonalcoholic steatohepatitis and hepatocellular carcinoma:: Natural history? [J].
Cotrim, HP ;
Paraná, R ;
Braga, E ;
Lyra, L .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2000, 95 (10) :3018-3019
[7]   Characterization of pathogenic and prognostic factors of nonalcoholic steatohepatitis associated with obesity [J].
García-Monzón, C ;
Martín-Pérez, E ;
Lo Iacono, O ;
Fernández-Bermejo, M ;
Majano, PL ;
Apolinario, A ;
Larrañaga, E ;
Moreno-Otero, R .
JOURNAL OF HEPATOLOGY, 2000, 33 (05) :716-724
[8]   Non-alcoholic steatohepatitis and GB virus-C hepatitis G virus infection: Is there a causal relationship? [J].
Kiyosawa, K .
INTERNAL MEDICINE, 1997, 36 (04) :236-237
[9]   NONALCOHOLIC STEATOHEPATITIS - A STUDY OF 49 PATIENTS [J].
LEE, RG .
HUMAN PATHOLOGY, 1989, 20 (06) :594-598
[10]  
LUDWIG J, 1980, MAYO CLIN PROC, V55, P434